The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times

Radiotherapy and Oncology

Volumn 76, Issue 2, 2005, Pages 135-142

  Eriksen, Jesper Grau ^a,b   Alsner, Jan ^a   Steiniche, Torben ^a   Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

DHPLC; Head and neck; Mutation; Radiotherapy; Squamous cell carcinoma; TP53

Indexed keywords

MUTANT PROTEIN; PROTEIN P53;

ADULT; AGED; CANCER CONTROL; CANCER SURVIVAL; CANCER THERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; GENE MUTATION; HEAD AND NECK CARCINOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTANT; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RADIOSENSITIVITY; REDUCTION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUTATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 28444487382     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.05.004     Document Type: Conference Paper

References (28)

1. M. Baumann, and M. Krause Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results Radiother Oncol 72 2004 257 266
2. H.R. Withers, J.M. Taylor, and B. Maciejewski The hazard of accelerated tumor clonogen repopulation during radiotherapy Acta Oncol 27 1988 131 146
3. Overgaard J. Phase III studies of novel fractionation schedules in radiotherapy of head and neck carcinoma. In: Kogelnik HD, Likas P, Sedlmayer F, editors. Progress in radio-oncology VII. Bologna: Monduzzi Editore; 2002, p. 423-430
4. J. Bourhis, N. Syz, and J. Overgaard Conventional vs. modified fractionated radiotherapy. Meta-analysis of radiotherapy in head and neck squamous cell carcinoma: a metaanalysis based on individual patient data Int J Radiat Oncol Biol Phys 54 2002 71 72
5. K.K. Fu, T.F. Pajak, and A. Trotti A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16
6. J. Overgaard, H.S. Hansen, and L. Specht Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial Lancet 362 2003 933 940
7. C. Grau, H.S. Hansen, and L. Specht Acute and late normal tissue reactions in the DAHANCA 6&7 randomized trial with accelerated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 57 2003 S154
8. Y. Matsui, Y. Tsuchida, and P.C. Keng Effects of p53 mutations on cellular sensitivity to ionizing radiation Am J Clin Oncol 24 2001 486 490
9. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
10. T. Soussi, and C. Beroud Assessing TP53 status in human tumours to evaluate clinical outcome Nat Rev Cancer 1 2001 233 240
11. A. Kropveld, E.H. Rozemuller, and F.G. Leppers Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers Lab Invest 79 1999 347 353
12. J. Overgaard, H.S. Hansen, M. Overgaard, L. Bastholt, A. Berthelsen, L. Specht, B. Lindelov, and K. Jorgensen A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85 Radiother Oncol 46 1998 135 146
13. J. Alsner Isolation and sequencing of heteroduplex fragments from DHPLC analysis of somatic, low-frequency mutations K.H. Hecker Genetic variance detection Nuts and bolts of DHPLC in genomics 2003 DNA Press LLC 163 173
14. J.G. Eriksen, T. Steiniche, J. Alsner, J. Askaa, and J. Overgaard The prognostic value of Epidermal Growth Factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck Int J Radiat Oncol Biol Phys 58 2004 561 566
15. U. Hauser, V. Balz, T.E. Carey, U. Bockmühl, I. Petersen, and H. Bier Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region Head Neck 24 2002 868 873
16. H. Blons, and P. Laurent-Puig TP53 and head and neck neoplasms Hum Mutat 21 2003 252 257
17. P.K. Ha, and J.A. Califano The molecular biology of mucosal field cancerization of the head and neck Crit Rev Oral Biol Med 14 2003 363 369
18. A.J. Levine p53, the cellular gatekeeper for growth and division Cell 88 1997 323 331
19. J.G. Eriksen, T. Steiniche, and J. Overgaard The influence of Epidermal Growth Factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6&7 study Radiother Oncol 73 2005 93 100
20. J.G. Eriksen, F.M. Buffa, J. Alsner, T. Steiniche, S.M. Bentzen, and J. Overgaard Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas Radiother Oncol 72 2004 275 282
21. D. Taylor, W.M. Koch, M. Zahurak, K. Shah, D. Sidransky, and W.H. Westra Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations Hum Pathol 30 1999 1221 1225
22. J. Alsner, S.B. Sorensen, and J. Overgaard TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck Radiother Oncol 59 2001 179 185
23. P. Fei, and W.S. El Deiry P53 and radiation responses Oncogene 22 2003 5774 5783
24. J. Alsner, M. Hoyer, S.B. Sorensen, and J. Overgaard Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 49 2001 519 525
25. K. Pekkola-Heino, K. Servomaa, A. Kiuru, and R. Grenman Increased radiosensitivity is associated with p53 mutations in cell lines derived from oral cavity carcinoma Acta Otolaryngol 116 1996 341 344
26. K. Servomaa, A. Kiuru, R. Grenman, K. Pekkola-Heino, J.O. Pulkkinen, and T. Rytomaa p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines Cell Prolif 29 1996 219 230
27. J.R. Grandis, Q. Zeng, S.D. Drenning, and D.J. Tweardy Normalization of EGFR mRNA levels following restoration of wild-type p53 in a head and neck squamous cell carcinoma cell line Int J Oncol 13 1998 375 378
28. M.L. Gillison Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity Semin Oncol 31 2004 744 754